Industrial Materials
Compare Stocks
2 / 10Stock Comparison
IPX vs AMTX
Revenue, margins, valuation, and 5-year total return — side by side.
Oil & Gas Refining & Marketing
IPX vs AMTX — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Industrial Materials | Oil & Gas Refining & Marketing |
| Market Cap | $1.27B | $221M |
| Revenue (TTM) | $0.00 | $198M |
| Net Income (TTM) | $-70M | $-77M |
| Gross Margin | — | -0.4% |
| Operating Margin | — | -18.8% |
| Total Debt | $4M | $318M |
| Cash & Equiv. | $55M | $5M |
IPX vs AMTX — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jun 22 | May 26 | Return |
|---|---|---|---|
| IperionX Limited (IPX) | 100 | 650.9 | +550.9% |
| Aemetis, Inc. (AMTX) | 100 | 66.0 | -34.0% |
Price return only. Dividends and distributions are not included.
Quick Verdict: IPX vs AMTX
Each card shows where this stock fits in a portfolio — not just who wins on paper.
IPX is the clearest fit if your priority is long-term compounding.
- 436.2% 10Y total return vs AMTX's 12.1%
- 1.8% margin vs AMTX's -39.0%
AMTX carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- beta 1.46
- Rev growth -22.3%, EPS growth 33.0%, 3Y rev CAGR -6.8%
- Lower volatility, beta 1.46, current ratio 0.07x
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | -22.3% revenue growth vs IPX's -3.4K% | |
| Quality / Margins | 1.8% margin vs AMTX's -39.0% | |
| Stability / Safety | Beta 1.46 vs IPX's 2.14 | |
| Dividends | Tie | Neither stock pays a meaningful dividend |
| Momentum (1Y) | +159.2% vs IPX's +67.7% | |
| Efficiency (ROA) | -31.3% ROA vs IPX's -69.2%, ROIC -70.3% vs -96.2% |
IPX vs AMTX — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
IPX vs AMTX — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
IPX leads this category, winning 1 of 1 comparable metric.
Income & Cash Flow (Last 12 Months)
AMTX and IPX operate at a comparable scale, with $198M and $0 in trailing revenue.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $0 | $198M |
| EBITDAEarnings before interest/tax | -$72M | -$28M |
| Net IncomeAfter-tax profit | -$70M | -$77M |
| Free Cash FlowCash after capex | -$55M | -$23M |
| Gross MarginGross profit ÷ Revenue | — | -0.4% |
| Operating MarginEBIT ÷ Revenue | — | -18.8% |
| Net MarginNet income ÷ Revenue | — | -39.0% |
| FCF MarginFCF ÷ Revenue | — | -11.5% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | -7.9% |
| EPS Growth (YoY)Latest quarter vs prior year | +174.3% | +77.5% |
Valuation Metrics
IPX leads this category, winning 1 of 1 comparable metric.
Valuation Metrics
| Metric | ||
|---|---|---|
| Market CapShares × price | $1.3B | $221M |
| Enterprise ValueMkt cap + debt − cash | $1.2B | $534M |
| Trailing P/EPrice ÷ TTM EPS | -31.46x | -2.53x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | — | — |
| Price / SalesMarket cap ÷ Revenue | — | 1.06x |
| Price / BookPrice ÷ Book value/share | 12.03x | — |
| Price / FCFMarket cap ÷ FCF | — | — |
Profitability & Efficiency
AMTX leads this category, winning 4 of 7 comparable metrics.
Profitability & Efficiency
On the Piotroski fundamental quality scale (0–9), AMTX scores 4/9 vs IPX's 2/9, reflecting mixed financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | -78.5% | — |
| ROA (TTM)Return on assets | -69.2% | -31.3% |
| ROICReturn on invested capital | -96.2% | -70.3% |
| ROCEReturn on capital employed | -52.7% | -19.0% |
| Piotroski ScoreFundamental quality 0–9 | 2 | 4 |
| Debt / EquityFinancial leverage | 0.04x | — |
| Net DebtTotal debt minus cash | -$51M | $313M |
| Cash & Equiv.Liquid assets | $55M | $5M |
| Total DebtShort + long-term debt | $4M | $318M |
| Interest CoverageEBIT ÷ Interest expense | -207.07x | -0.61x |
Total Returns (Dividends Reinvested)
IPX leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in IPX five years ago would be worth $53,622 today (with dividends reinvested), compared to $1,952 for AMTX. Over the past 12 months, AMTX leads with a +159.2% total return vs IPX's +67.7%. The 3-year compound annual growth rate (CAGR) favors IPX at 74.5% vs AMTX's 12.6% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | -5.4% | +103.8% |
| 1-Year ReturnPast 12 months | +67.7% | +159.2% |
| 3-Year ReturnCumulative with dividends | +430.9% | +42.7% |
| 5-Year ReturnCumulative with dividends | +436.2% | -80.5% |
| 10-Year ReturnCumulative with dividends | +436.2% | +12.1% |
| CAGR (3Y)Annualised 3-year return | +74.5% | +12.6% |
Risk & Volatility
AMTX leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
AMTX is the less volatile stock with a 1.46 beta — it tends to amplify market swings less than IPX's 2.14 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. AMTX currently trades 85.3% from its 52-week high vs IPX's 61.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 2.14x | 1.46x |
| 52-Week HighHighest price in past year | $61.45 | $3.80 |
| 52-Week LowLowest price in past year | $19.43 | $1.22 |
| % of 52W HighCurrent price vs 52-week peak | +61.4% | +85.3% |
| RSI (14)Momentum oscillator 0–100 | 55.1 | 70.0 |
| Avg Volume (50D)Average daily shares traded | 280K | 1.7M |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Wall Street rates IPX as "Buy" and AMTX as "Buy". Consensus price targets imply 23.2% upside for IPX (target: $47) vs -46.0% for AMTX (target: $2).
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy |
| Price TargetConsensus 12-month target | $46.50 | $1.75 |
| # AnalystsCovering analysts | 2 | 7 |
| Dividend YieldAnnual dividend ÷ price | — | — |
| Dividend StreakConsecutive years of raises | — | — |
| Dividend / ShareAnnual DPS | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% |
IPX leads in 3 of 6 categories (Income & Cash Flow, Valuation Metrics). AMTX leads in 2 (Profitability & Efficiency, Risk & Volatility).
IPX vs AMTX: Frequently Asked Questions
8 questions · data-driven answers · updated daily
01Is IPX or AMTX a better buy right now?
Analysts rate IperionX Limited (IPX) a "Buy" — based on 2 analyst ratings — the highest consensus in this comparison.
The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — IPX or AMTX?
Over the past 5 years, IperionX Limited (IPX) delivered a total return of +436.
2%, compared to -80. 5% for Aemetis, Inc. (AMTX). Over 10 years, the gap is even starker: IPX returned +436. 2% versus AMTX's +12. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — IPX or AMTX?
By beta (market sensitivity over 5 years), Aemetis, Inc.
(AMTX) is the lower-risk stock at 1. 46β versus IperionX Limited's 2. 14β — meaning IPX is approximately 47% more volatile than AMTX relative to the S&P 500.
04Which is growing faster — IPX or AMTX?
On earnings-per-share growth, the picture is similar: Aemetis, Inc.
grew EPS 33. 0% year-over-year, compared to -20. 0% for IperionX Limited. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — IPX or AMTX?
IperionX Limited (IPX) is the more profitable company, earning 0.
0% net margin versus -37. 0% for Aemetis, Inc. — meaning it keeps 0. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: IPX leads at 0. 0% versus -17. 9% for AMTX. At the gross margin level — before operating expenses — IPX leads at 0. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Which pays a better dividend — IPX or AMTX?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
07Is IPX or AMTX better for a retirement portfolio?
For long-horizon retirement investors, Aemetis, Inc.
(AMTX) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding. IperionX Limited (IPX) carries a higher beta of 2. 14 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (AMTX: +12. 1%, IPX: +436. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
08What are the main differences between IPX and AMTX?
These companies operate in different sectors (IPX (Basic Materials) and AMTX (Energy)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.